シェアードリサーチ社企業分析レポート - 3D MATRIX [medical technology]
Contents
1. pH2. Scaffold GLP Good Laboratory Practce 1 http www sharedresearch jp 25 28 Shared
3. 2012 4 2013 4 TDM 621
4. 3 III 1 1 2 II 3 1 1
5. TDM 64 1 TDM 64 1 EE TDM 641 TDM 64 1 TDM 621 RA
6. SR Inc SR Inc http7Xwww sharedresearchJp 28 28 Shared esearch
7. 1992 MIT Shuguang Zhang R A D 3 RADA 16 pH ADME
8. 3 MIT 1 2 3 3
9. MIT MIT MIT 2001 5 http7www sharedresearchJp 13 7 28 Shared 68 ese aTCh 2012 6 21 7777 3 D Matrix Inc m 3 D Matrix Tnc 100 mm 3 D Matrix Europe SAS 100
10. 589 66 3 583 88 3 529 71 4 11 4 12 4 13 4 1 4 15 15B 1 107 2 491 3 H45 H O0G 2 25 1 5 592 775 4 499 71 1 117 1 298 2 354 5 1 091 5 1 510 310 1 1 085 3 515 5 4 309 5 9 2 USR TE 2012 6 14 2015 4 2 lt 3
11. C http7Xwww sharedresearchJp 8 28 hared Wesearch a 2012 6 21 7777 _ 1987 C 1 2008 1 30 2008 12 14 5 1 2009 11 30 2010 1 2007 12
12. TOP TOP 1 http www sharedresearch jp 27 28 s Shared Wesearch 2012 6 21 SR 2012 6 21 3076 05 18 12 6754 06 11 12 9882 05 11 12 4847 05 15 12 2492 05 10 12 6750 06 12 12 4849 06 21 12 8016 06 12 12 4583 06 12 12 4763 06 12 12 8999 06 05 12 6249 06 05 12
13. a TDM 621 RADA16 TDM 621 TDM 621 TDM 621 TDM 621 pH lt gt TDM B2 1 TDM Bg1 L
14. mm 2015 4 2015 4 m TDM 621 m 2013 4 m 2013 4 2014 4 m 2013 4 2015 4 m 2013 4 CE EU
15. 2012 4 3 D Matix Europe SAS 3 D Matrix Inc 2007 10 3 D Matrix Inc 2009 4 TOP amp TOP 3DM Investment LLC MIT 3 D Matrix Inc 1 http www sharedresearch jp 23 28 hared Wesearch 2012 6 21 7777 TOP
16. 1 4 1 MIT MIT 2 3 4
17. R Arg ADME ADME Absorpton Distribution Metabolism Excreton ADME SIRNA 21 23 RNA siRNA RNA RNAi RNA mRNA MTA Material Transfer Agreement
18. m TOP http7 www sharedresearchjp 15 7 28 Shared 05Wesearch 2012 6 21 7777 CE OO 7 000 200 5 811 0 058 5g14 5 931 Es 180 4 173 0 J 34 0171 3170 7 5 000 5D 4 0n0 3 000 i ho Lm 2 000 1 000 UU 0 2009
19. 2012 4 3 D Matrix Inc 70 2019 4 m 2007 10 579 1 448 3DM Investmen LLC Massachusetts Insttute of Technology 2009 11 500 1 250
20. F TDM 711 TDM 711 GLP TDM 711 2010 9 FDA IDE 2011 7 IDE 2012 2 Forsyth Insttute C DDS DDS
21. 300 6 2016 1 344 iDATA Research 30 50 2016 1 344M cm ipara 1 600 F MB 1 400 1 200 1 0OD 800 00 a 400 zn CYOG CTYU7 CYOB CTO9 CYIOE CTYT11E CYIZE CT13E CTY14E CT15E CY16E EALANTS HEMOSTATS m 80 10 m
22. RADA16 ey 3 4 gt GE Il II A Sa 6 oO A A A A _ A 10 gt _
23. 2 491 124 9 TDM 621 PMDA TDM 621 2012 4 TDM 621 1 000 MR
24. Ra ROE SR 1 5 d U 7 10 4 11 4 12 402 158 1 10r 5 5 9 5 4G7 1 75 97 9 17 5 4H2 354 16 8 304 39 0 50 510 310 8 51 534 309 97 9 3 392 3 792 EY 197 147 2 7 7 gn Qn Qn no 344 1 UMIW 4 25 1 5 5 1 75g 94 GG 2 501 7 5 19 2 El yu 5Q5 4 7 1 198 1 199 3 055 12 1 20 0 0 0 31 49 112 0 0 Q 0 0 5 81 49 16r 1 16 1 150 2 HBB 0 0 0 2 434 131 13 18 100 5 9 1 400 d d4 14 4d 15 7 d 5 http www sharedresearch jp 1 28 2012 6 21 7777 2012 6 18 TDM 711
25. JASDAQ7774 2002 2370 COO 2003 10 2005 2007 1998 1 2005 2007 INSEAD MBA TOP 2011 8 20 18 39 8 2 2
26. sr_inquiries sharedresearch jp ng 4 13 4 1 1 5 i pt ta hh 4 LE 7 1 4 158 na 10 805 2 9 2 EFS EPS DPS Qn BPS 48 1 10G 38
27. TDM 621 2012 4 1 4521 TDM 621 1 000 MR 100 TDM 621 MR 700 Daewoong Pharmaceutcal Co LTD Excelsior Medical Co Ltd
28. MIT CSL amp 1 4502 2009 Medmarket Diligence 1 4503 lt 1 3401 gt CSL
29. 30 DDS MIT MIT PuraMatrix PuraMatrix 1 1 3 NE GEE EE Ac R A D A R A D A RA DA RA DA CONH a 1
30. TOP t Qa 4 09 4 10 4 11 4 12 4 13 4 10 10 402 158 1 107 2 49 1 BU 3 4 5 6 dg 194 9 1 9 3 398 111 39 95 3 55 4D5 499 71 57 1 75 1 902 5 2 354 TE 9 ti 11 0 3 5 27 4 259 50 510 310 1 8 8 MK Li 3 1 a1 1 9 1 5 4 309 5 i 7 91 9 MSR 1 http www sharedresearch jp 19 28 hared Wesearch 2012 6 21
31. _ SE TDM 621 2010 1 97 2011 4 a 2 TDM 621 5 lt 7
32. SR Weaknesses m MIT MIT 2014
33. 2 3 4 PMDA FDA 5 PMDA FDA 6 2 3 7 TDM 621 TDM 711 TDM 641 TDM 631 TDM 621 RADA16
34. 2012 4 100 MTA MTT MIT 3 D Matrix Inc 2003 4 MIT Exclusive Patent License Agreement MIT 2004 10 3 D Matrix Inc License and Supply Agreement 3 D Matix In
35. http7 www sharedresearchjp 3 728 Shared 05Wesearch 2012 6 21 7777 100 TDM 621 MR 700 2012 6 2011 10 1 902 152 5 533 971 398
36. 2013 4 1 KOL Key Opinion Leader 2011 11 mm 2014 4
37. m 2011 Phase 1 2013 4 12 400 0 1 107 2 49 1 599 5 124 9 7 154 2951 5 31 3 99 91 BE 5 7 1 tent 4 451 39 5 2 5 354 5HB Bi 14 1 39H 93 9 301 310 5 Bi 9 4 98 34 9 300 309 USR fF
38. 2 3 4 DDS http
39. 8 a TDM 711 TDM 711 TDM 711 3 TDM 711
40. 482 2010 4 65 510 60 534 61 m TDM 621 2010 4 2011 4 PMDA 2010 8 2010 9 Daewoong Pharmaceutcal Co LTD PARTNERSHIP AGREEMENT Excelsior Medical Co Ltd LICENSE AGREEMENT m TDM 711 2011 3 FDA IDE IDE 3
41. 2010 8 13B1X10105 3 D Matrix Inc IDE FDA Daewoong Pharmaceutical Co LTD PARTNERSHIP AGREEMENT Excelsior Medical Co Ltd LTCENSE AGREEMENT 2009 4 2010 9 PMDA PMDA 2011 5 3 D Matrix Inc FDA IDE 2012 2
42. 2009 4 1 8001 TDM 621 Daewoong Pharmaceutical Co LTD Excelsior Medical Co Ltd http7Xwww sharedresearchJp 12 28 s Shared Wesearch 2012 6 21 7777 TDM 64 1 m 2
43. 2023 3 16 3 US dd 20qg 11 3Q 2021 2 5 Puraluatrix EP F17398 0 EL 200B 12 31 an2o 2 5 1 1E PCT SR 3 L Matrix jnc MIT ENDEH A RESTATED ECLUSTVE PTENT LICENSE AGREEhAERT J FIRST ENDMENT SECOhID kMEMDIENT THIRD AhAENDAENT TO ENPED A a IIT hi katrix mc MIT MSR 2014
44. m 2015 4 SR 2015 4 2011 10 2012 6 I a TOP 1 http www sharedresearch jp 5 28 Shared Wesearch 2012 6 21 7777 Massachusetts Insttute of Technology MIT
45. Drug Delivery System pH bFGF PDGF
46. m 2011 Phase 1 2012 4 2 2011 12 9 2012 4 2 2 400 TDM 621 400 341 59 9 9 2 535
47. 1 4559 AH TOP
48. PII II 1 2 3 TDM 621 2009 2013 4 http7Xwww sharedresearchJp 14 28 hared Wesearch 2012 6 21 7777 3 4
49. http goo gl RbT3d 1 100 550 300 456 256 477 255 478 TDM 621 TDM 621 1 4538 1 4521 2012 4 9 TDM 621
50. EU CE 2014 4 2015 4 TDM 641 2013 4 2014 4 2015 4 TDM 631 2014 4 2015 4 TDM 711 2012 2 2014 4 2015 4 m http7Xwww sharedresearchJp 4 28 s Shared Wesearch 2012 6 21 7777
51. mm TDM 711 2011 7 FDA 1IDE 2012 4 1 400 TDM 621 400 190 210 204 204 http7 www sharedresearchjp 18 28 Shared 05Wesearch 201276 21 7777 m TDM 621 2011 4 1
52. PuraMatrix R A D 16 RADA16 2 http7 www sharedresearchjp 26 28 Shared 05Wesearch 201276 21 7777
53. SW Strengths Weaknesses Strengths m MIT m m
54. 160 2008 1 2009 3 TDM 621 TDM 621 q 1 Informed Consent 2 3 TDM 621
55. http goo gl GHgKe TDM 621 3 amp IPG 12 4 je 2Q On 0 rr 100 1 100 ror qn 47 ds5 120 roar 150 104 112 132 rar 210 151 157 5 118 1 W nn ror 59 5 3 204 195 158 dG 120 5W 2 roar 51 Bd 20d 19 159 d5g 121 rar 51 1W BMW USR TF http7Xwww sharedresearch p 2 28 Shared amp esearch 201276 21 7777 2012 4 2012 6 13 2012 4
56. SR KOL Key Opinion Leader TOP http7Xwww sharedresearchJp 17 28 s Shared Wesearch 2012 6 21 7777 2012 4 3
57. https www release tdnet info inbs 140120120618057999 pdf TDM 711 Forsy Insttute 2012 2 15 FDA 2012 6 13 2012 4 http goo gl aMt42 2012 4 2012 4 12 2012 4
58. 1009 60 70 MIT SR CRO
59. TDM 621 97 2012 4 m http7Xwww sharedresearchJp 7 28 s Shared Wesearch 2012 6 21 7777 1 2012 2012 3 2012 2012 2 A
60. 7777 QB 4 ng 4 1 11 5 1 758 393 39 25 17 39 718 594 41 2 501 5 BB 19 2 30 5 7 7 397 9 qo 5 5 4 604 5 5 9 733 1 19H 1 199 3 055 12 15 29 d Pl an ta 0 0 0 15 9 5 31 49 112 0 0 0 5 0 0 5 0 0 0 1 49 157 1 1Qg 1 35g 2 070 1 QgG 1 34g 2 0G 1 n5 1 5BG 1 2 11 18 958 5 1 1857 1 150 7 HH 21 22 3 0 0 544 5 B 1 758 MSR
61. CE EU EU CE 2013 4 CE 2015 4 2012 4 TDM 621 2011 5 1 4538 10
62. DDS bDFGF PDGF A6K siRNA DDS
63. 3360 06 18 12 3046 06 05 12 2453 06 20 12 7777 06 21 12 9793 06 12 12 4819 06 12 12 7532 06 19 12 4571 06 05 12 7777 6324 06 06 12 05 10 12 IS 4283 05 22 12 8423 05 25 12 2767 05 29 12 6890 05 30 12 9904 06 08 12 944 1 06 14 12 3730 05 21 12 7541 06 01 12 2370 06 20 12 4680 06 08 12
64. MIT MIT Scientfic Founders 2007 10 3 D Matix Inc http7Xwww sharedresearchJp 22 28 s Shared Wesearch 7777 1992 MIT Shuguang Zhang 2001 5 MIT 3 D Matrix Inc 3 D Matrix Inc MIT Exclusive Patent License Agreement D 9 2003 4 2004 5 3 D Matrix Inc LICENSE AN
65. TOP 3 D Matrix Inc 2004 3 D Matrix Inc 2000 4 MBA 1999
66. 169 165B 6 1 1 1 7 10 11 12 13 1 m 170 TDM 621 50
67. TDM 621 TDM 621 TDM 621 a http7 www sharedresearchjp 9 28 Shared 059esearch 2012 6 21 7777 TDM 621 re
68. 4 JAIC TAIB JAIC Asian Balanced Private Equity Fund m 2010 9 200 400 m 2010 9 300 600 Excelsior Medical Co Ltd Daewoong Pharmaceutcal Co LTD 2011 10 1 352 700 1 http7Xwww sharedresearchJp 20 28 Shared Wesearch 2012 6 21 7777 nH 4 og 1 4 11 4 0 TN 5 4 5BB EFS 14 42 400 4 7B7O 5BBBG 737 EPS gn DPS nn nn nn nn nn BPS 137 22 7 52 137 G4 2 120 1595 25 1 2 792
69. 2011 5 PMDA TDM 621 1 4538 2012 4 1 4521 mm TDM 711 2011 7 FDA IDE 2012 2 Forsyth Insttute m TDM 641 2012 2 20
70. 2011 5 PMDA TDM 621 2012 2012 2012 4 TDM 621 2010 9 17 Daewoong Pharmaceutcal Co LTD PARTNERSHIP AGREEMENT Excelsior Medical Co Ltd LICENSE AGREEMENT 2012 2013 4 2015 4 2012 4
71. 2769 06 05 12 7455 06 01 12 2593 06 01 12 2362 06 12 12 6063 06 20 12 2353 06 07 12 6157 06 11 12 SR Inc SR Inc Shared Research SR Inc
72. PMDA TDM 621 TDM 621 m TDM 711 2011 7 FDA 1IDE 2011 4 158 2010 4 402 150 2010 4 400 64 1 2010 4 174 50 TDM 621 122
73. TDM 621 1 4538 TDM 621 m TDM 711 2011 7 FDA IDE 2012 2 m TDM 641 2012 2 20
74. TDM 631 TDM 631 TDM 631 X B http7Xwww sharedresearchJp 11 28 hared Wesearch 2012 6 21 7777
75. TOP IR 2 4 TOP http7Xwww sharedresearchJp 24 28 s Shared Wesearch 2012 6 21 7777 IDE Investgatonal Device Exemption FDA D D Asp COOH NH2 A amp A Ala R
76. siRNA PuraMatrix Becton Dickinson and Company m CPC Scientific Inc 3 3 1 TDM 621 2011 5
77. 22 434 131 13 18 100 FGF 1 12 40 5 1 5 4 1 400 1 5 79 9 11 10 90 C 1 20 FCF NHA B C 457 1 SR TOP http7 Www sharedresearchjp 21 28 Shared Wesearch 2012 6 21 7777 TDM 641 Massachu
78. Daewoong Pharmaceutcal Co LTD Excelsior Medical Co Ltd 14 000 1cc SR b TDM 641 TDM 641 TDM 64 1 http7 www sharedresearchjp 10 28 Shared 05Wesearch 2012 6 21 7777
79. 2011 4 1 385 685 2011 10 24 JASDAQ 2011 10 23 676 m TDM 621 2011 5 PMDA TDM 621 TDM 621
80. 2012 3 9 2012 4 3 3 400 TDM 621 400 498 98 14 26 7 52 149 150 m TDM 621 2011 5 PMDA
81. PDF http www sharedresearch jp 77
82. 113 685 11 526 m 60 10 5 6 Millennium Research Group http7Xwww sharedresearch p 16 28 Shared 9esearch 201276 21 7777 DO 5 69 1 600 49 1 400 ie PrnprietarY 1 200 en 1 800 Nonpropristary 1 2 co SOO 8 1 ed a Millenmium Rmsaarch roup US Markel for Denlal Bhomatearals 0 2010 2008 2009 2010 2011 2012 2013 2014
83. Wesearch 2012 6 21 7777 pH DDS
84. 1 107 1 TDM 621 2 TDM 64 1 3 7Z53 354 3 14 26 48 310 309 2012 4 300 m TDM 621
85. 7Xwww sharedresearchJp 6 28 hared Wesearch 2012 6 21 7777 DDS MTA m
86. 9 17 3 9 792 5 EFS 105 0 1 7 147 2 737 EPS Gain DPS nn nn nn nn nn BPS 343 1 2435 344 1 300 4 G25 USR 2011 7 1 100 948 m 2011 8 1 4 3 792 2012 6 445 200 445 200 2012 4 4 588 800 10 TOP 0H 4 09 4 10 4 11 4 12 4
87. D SUPPLY AGREEMENT 3 D Matrix Inc PuraMatrix 2007 10 3 D Matrix Inc Becton Dickinson and Company SUPPLY AGREEMENT PuraMatrix RADA16 2004 10 2008 2 2008 3 2008 10 2009 7 2009 8 PMDA
88. DA16 TDM 621 TDM 641 2012 4 2012 2 c TDM 631 RADA16 TDM 631 TDM 631 TDM 631
89. c 2007 10 3 D Matix Inc 3 D Matrix Inc MIT sehn or4 1 2 NHK MT 2003 4 15 2017 7 21 Purahdatrix 1F WO 067014570 a 0 E _ NM
90. setts Insttute of Technology MIT Shuguang Zhang 2004 5 1992 MIT Shuguang Zhang MIT MIT 2001 5 3 D Matrix Inc 2004 5 2004 10 3 DMatrix Inc LICENSE AND SUPPLY AGREEMENT 3 D Matix Inc
Download Pdf Manuals
Related Search